ReleaseWire Connect

As the ENFit transition continues across the globe, NeoMed is ready and willing to support and facilitate hospital and healthcare facility transitions to ENFit (ISO 80369-3). To ensure a smooth and seamless conversion, NeoMed has created the ENFit Transition Support Program, designed specifically to assist Premier members during their switch to ENFit. NeoMed developed this rebate program not only to incentivize Premier members to switch to NeoConnect®, but also to confirm NeoMed's unwavering commitment to support a smooth ENFit transition from hospital to home.

NeoMed is pleased to announce the launch of the new NeoConnect DoseMate DL (Directional Long) – an innovative and ergonomic solution for gentle, direct oral medication administration with an ENFit syringe. This new, patent-pending pharmacy accessory is ideal for dosing oral medications directly to the patient's cheek or back of the mouth.

U.S. News and World Report recently ranked the fifty leading U.S. children's hospitals specializing in pediatric neonatology in their annual Best Children's Hospitals rankings report. NeoMed® is proud to report that four of the top five highest-ranked pediatric neonatology hospitals in the U.S. rely on NeoMed products to deliver nutrition to the most fragile patients.

NeoMed, Inc. announces the launch of the "NeoConnect® Certification Program for ENFit®." The curriculum was developed as an essential resource to assist NeoMed customers during the global transition to ENFit. The NeoConnect Certification Program is designed for clinicians to demonstrate and document clinical competency with managing the use of ENFit products to enhance patient outcome by addressing essential topics such as: Compliance with GEDSA Guidelines to administer low volume doses using the Low Dose Tip Syringe, Impact of the moat during small volume doses to preserve dose accuracy, Identifying protocol changes, Maintaining current processes, Characterizing successful facility transitions, Enhancing productivity, Maximizing Ease of Use and Feeding tube hub cleaning procedures that support ASPEN recommendations.

NeoMed, has received FDA 510(k) clearance for our NeoConnect Low Dose Tip (LDT) Oral/Enteral ENFit Syringes. NeoMed's LDT ENFit Syringes, when used as intended, achieve accurate low dose Oral Medication delivery while minimizing the risk of misconnections.